Biogen's new Cambridge office tries bold architectural plan

Walk into Biogen Idec's ($BIIB) new complex in Cambridge, MA, and you might notice something's missing--there are no cubicles or private offices in the 6-story, 190,000-square-foot office, reports The Boston Globe. The biotech designed its new building with plenty of open space plus individual workstations called "I spaces" and designated areas for groups of people called "huddle rooms," all intended to encourage collaboration. Story

Suggested Articles

IBM and Pfizer developed an artificial intelligence model that could eventually predict if a person will develop Alzheimer’s using a language test.

After teaming up with other Big Pharmas to bolster antibiotics research, Pfizer is adding a new antibiotic prospect to its pipeline.

The oral direct-acting antiviral is set to enter a phase 3 trial in non-hospitalized patients early next year.